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Abstract 
 Stable tubule-only polypeptide (STOP) proteins are a family of microtubule associated 
proteins (MAPs) important in microtubule stabilization. Data indicating a role for 
microtubules in synaptic function has come from studies of the STOP null mouse, which 
exhibits synaptic deficits, in association with behavioural changes that are alleviated by 
antipsychotic treatment. These findings suggested that STOP mutant mice may be useful in 
studies of synaptic function, and could be especially relevant to schizophrenia, postulated to 
be a disorder of the synapse. Moreover, a genetic association between STOP and 
schizophrenia has been reported. This study aimed to further characterise synaptic alterations 
in STOP null and heterozygous mice. Using in situ hybridization histochemistry, the mRNA 
expression of three pre-synaptic (synaptophysin; growth associated protein-43: GAP-43; 
vesicular glutamate transporter-1: VGlut1) and two post-synaptic (spinophilin; MAP2) 
proteins, was quantified in female STOP null (n=7), heterozygous (n=5) and wild type (n=6) 
mice. For STOP null and heterozygous mice, synaptophysin, VGlut1, GAP-43 and 
spinophilin mRNAs were decreased in the hippocampus, whilst in addition in the null mice, 
synaptophysin, VGlut1 and spinophilin mRNAs were decreased in the cerebellum. Alterations 
in synaptic protein mRNA expression were also detected in the frontal and occipital cortex. 
MAP2 mRNA expression was unchanged in all brain regions. The profile of mRNA changes 
is broadly similar to that observed in schizophrenia. Together the data provide supporting 
evidence for a role for microtubules in synaptic function, and suggest that STOP, or other 
microtubule proteins, may contribute to the synaptic pathology of schizophrenia.  
 
Key words: in situ hybridization histochemistry; MAP6; microtubules; mRNA; 
schizophrenia; synapse. 
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Introduction 
STOP (stable tubule-only polypeptide) proteins are a family of calmodulin binding 
and regulated microtubule associated proteins (MAPs), encoded by a single gene (mouse: 
Mtap6, Denarier et al., 1998b; human: MAP6; Bosc et al., 2003), which play a role in 
microtubule stabilization in several cell types (Denarier et al., 1998a; Aguezzoul et al., 2003). 
The major STOP isoforms, N-STOP and E-STOP, are expressed by neurons (Bosc et al., 
1999; Guillaud et al., 1998), whereas fibroblasts express F-STOP (Denarier et al., 1998a) and 
astrocytes and oligodendrocytes express A-STOP and O-STOP respectively (Galiano et al., 
2004). In neurons, microtubule stabilization has been demonstrated to be important in 
neuronal migration (Schaar and McConnell, 2005; Tsai and Gleeson, 2005), morphology and 
function (Baas and Heidermann, 1986; Guillaud et al., 1998). Hence, like other MAPs (Mack 
et al., 2000; Takei et al., 2000; Feng and Walsh, 2001; Moores et al., 2004), STOP proteins 
are thought to play a role in normal brain development and synaptic connectivity. 
To evaluate the role of STOP proteins, gene targeting was used to create the STOP 
null mouse (Andrieux et al., 2002). In association with impaired synaptic plasticity and 
decreased size of synaptic vesicle pools, STOP null mice exhibit behavioural changes, 
including disorganized activity, social withdrawal and nurturing defects, the latter of which 
were alleviated with long term typical antipsychotic drug treatment. These initial findings 
suggested that STOP null mice may be useful in studies of synaptic function. They could be 
of particular interest with respect to schizophrenia, which is proposed to be a disorder of the 
synapse (see Mirnics et al., 2001; Moises et al., 2002; Frankle et al., 2003) and in which the 
expression of several synaptic proteins is decreased (see Honer et al., 2000), and perhaps with 
regard to mood disorders, in which microtubule dysfunction has been hypothesised (Bianchi 
et al., 2005). Subsequent studies of STOP null mice have demonstrated that both sexes exhibit 
behavioural changes relevant to schizophrenia, including sensorimotor gating deficits 
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(Fradley et al., 2005) and hyper-locomotor activity (Brun et al., 2005; Fradley et al., 2005), 
which is reversed by antipsychotic drugs (Brun et al., 2005; Fradley et al., 2005). In addition, 
dopaminergic changes are evident in STOP null mice. Amphetamine exacerbates the hyper-
locomotor activity (Brun et al., 2005), whilst evoked dopamine efflux is increased in the 
nucleus accumbens (Brun et al., 2005). Based in part upon post mortem findings of decreased 
hippocampal MAP2 protein in schizophrenia (Arnold et al., 1991), a role for microtubules in 
the pathophysiology of schizophrenia has been hypothesised (Kerwin, 1993). The finding of 
synaptic changes in STOP null mice (Andrieux et al., 2002) suggests that altered microtubule 
and synaptic function may be related, and contribute to the proposed pathogenic role of 
microtubules in schizophrenia. The aim of the current study was to further characterise 
synaptic alterations noted in the STOP null mouse in terms of the expression of pre- and post-
synaptic protein mRNAs, markers of synapses and synaptic function (see Discussion and 
Honer et al., 2000; Honer and Young, 2003; Law et al., 2004b; Eastwood and Harrison, 
2005), and to extend previous studies of STOP null mice by including heterozygous as well as 
wild type littermates. The pre-synaptic proteins, synaptophysin, growth-associated protein-43 
(GAP-43) and vesicular glutamate transporter-1 (VGlut1), and the post-synaptic protein 
spinophilin, were quantified as their expression has been reported to be altered in post mortem 
studies of schizophrenia (see Table 1). In addition, MAP2 mRNA was examined, firstly as a 
dendritic marker (see Discussion), and also to determine if deficits in STOP expression are 
compensated for by the increased expression of another MAP. We examined synaptic protein 
mRNAs, not only in the hippocampal CA1 subfield where synaptic vesicle pools in the STOP 
mice have been quantified, but extended it to include other hippocampal subfields, and 
additional brain regions, including the prefrontal cortex and cerebellum, all implicated in the 
pathophysiology of schizophrenia (Katsetos et al., 1997; Eastwood et al., 2001; Weinberger et 
al., 2001; Harrison, 2004).  
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Methods and Materials 
 Animals 
STOP mice were generated on a 50:50 BALBc/129 SvPas background as previously 
described (Andrieux et al., 2002), with gene targeting being used to replace exon 1 of the 
STOP gene with a non-functional construct. As the mRNAs of all of the STOP proteins 
characterised to date contain this exon (Denarier et al., 1998a, b), the expression of all STOP 
isoforms is suppressed in the null mice. Brains from 12 week old STOP null female mice 
(n=7), and their wild type (n=5) and heterozygote (n=6) littermates were snap frozen by 
immersion in isopentane chilled on dry ice, and stored at -80ºC until use. 
 
In situ hybridization histochemistry    
Frozen coronal sections (15 µm) were cut at the level of the dorsal hippocampus 
(approximately at Bregma -2.30 mm; Paxinos and Franklin, 2004), the caudate putamen 
(approximately at Bregma 0.86 mm), and cerebellum, and collected onto Superfrost Plus 
slides (VWR, Lutterworth, UK). Slides were pretreated for in situ hybridization 
histochemistry (ISHH) as described (Eastwood et al., 2000a), and stored at -20ºC. 
Oligonucleotide probes complementary to mouse STOP (bases 975-1009, Genbank accession 
number NM010837), synaptophysin (bases 846-884, NM009305), VGlut1 (bases 1562-1606, 
NM182993), GAP-43 (bases 599-628, NM008083), spinophilin (bases 1480-1519, 
AY508450), MAP2 (bases 698-739, BC052446) and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH; bases 201-239, BC095932) mRNAs were 3’ end labelled with 
[35S]dATP (Perkin Elmer, UK) using terminal deoxynucleotidyl transferase (Promega, 
Southampton, UK) and established protocols (Eastwood et al., 2001). Sections were incubated 
overnight (GAP-43, spinophilin, MAP2 and GAPDH: 33ºC; STOP: 35ºC; synaptophysin: 
34ºC; VGlut1: 42ºC) in hybridization buffer (Eastwood et al., 2000a) containing 1 million 
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counts per minute labelled probe and dithiothreitol (STOP, spinophilin, MAP2: 50mM; 
synaptophysin, GAP-43 and GAPDH: 20mM). For all transcripts except VGlut1 and GAP-43, 
post-hybridization washes were carried out with 1 X standard sodium citrate (SSC) at either 
55ºC (MAP2), 58ºC (spinophilin and GAPDH) or 60ºC (synaptophysin) for 3 X 20 minutes, 
followed by 2 X 60 minute washes at room temperature. For GAP-43, washes were carried 
out in 0.5 X SSC at 58ºC for 3 X 20 minutes followed by 2 X 60 minutes at room 
temperature. For VGlut1, post-incubation washes were as previously published (Miyazaki et 
al., 2003), and consisted of 2 X 40 minute washes at 55ºC in 0.1 X SSC. Triplicate sections at 
each anatomical level were run concurrently for each transcript, and the hybridized sections 
placed against Kodak Biomax MR film (GE Healthcare, Little Chalfont, UK) alongside 14C 
microscales (GE Healthcare) for the following times: GAP-43, 1 day; synaptophysin, 2 days; 
VGlut1, 3 days; GAPDH, 4 days; MAP2 and STOP, 7 days; spinophilin, 14 days. Negative 
controls consisted of incubation in the presence of 50 fold excess cold unlabelled probe and 
ISHH with sense orientation probes. 
 
Image and statistical analysis 
Autoradiographs were measured using an MCID Elite v7.0 image analysis system 
(Interfocus, Haverhill, UK). Optical density values obtained were calibrated to 35SnCi/g tissue 
equivalents using the 14C microscales and a conversion factor of 3, and corrected for non-
specific background signal as represented by either sense strand hybridization or incubation 
with excess unlabelled probe. 
 Measurements were taken over the granule cell layer of the dentate gyrus (DG), the 
pyramidal layer of CA3 and CA1, and through the depth of the overlying occipital cortex for 
sections taken at the level of the dorsal hippocampus. For the sections taken at the level of the 
caudate putatmen, measurements were taken over the dorsolateral quadrant of the caudate 
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putamen and through the depth of the fronto-parietal and cingulate cortex. Finally, signal was 
measured in the cerebellum over the granule cell layer. These areas are illustrated in Figure 1 
A, B and D.  
 All statistical analyses were performed using SPSS v 13 software. For each transcript, 
analysis of variance (ANOVA) was performed to determine if there was an overall effect of 
genotype or an area by genotype interaction. If either were significant (P<0.05), subsequent 
ANOVAs were conducted for each individual brain area, with significant differences between 




In order to confirm the genotype of each animal and also examine the distribution of 
STOP mRNA in the mouse brain (which has not been previously described), the 
oligonucleotide probe used was designed against exon 1 of STOP mRNA, missing in the 
mutant mice. STOP mRNA was detectable in all areas examined in wild type mice, with a 
weaker signal observed in heterozygous mice, but was not detected in the nulls (Fig. 1). Of 
the areas examined here, STOP mRNA signal was highest over the hippocampus, moderate 
over the occipital, fronto-parietal and cingulate cortex and cerebellum, with the weakest 
signal observed over the caudate putamen.  
 
Synaptophysin mRNA 
Synaptophysin mRNA distribution was as previously reported in rodents (Marquèze 
Pouey et al., 1991; Eastwood et al., 1997). In the overall ANOVA, a significant effect of 
genotype was detected (F2, 115=15.55, P<0.001), but not a genotype by area interaction (F14, 
115=0.95, P=0.51). There were significant effects of genotype upon synaptophysin mRNA in 
Altered synaptic protein mRNA expression in STOP mutant mice 8 
CA1, occipital and fronto-parietal cortex, and a trend towards significance in the cerebellum 
and cingulate cortex (Table 2). The significant effects of genotype were due to decreases in 
synaptophysin mRNA expression in STOP null and heterozygous mice as compared to the 
wild type mice (Table 2).  
 
VGlut1 mRNA 
VGlut1 mRNA was robustly detected in every area examined except the caudate 
putamen, in accordance with previous reports (Miyazaki et al., 2003). Genotype (F2, 98=18.61, 
P<0.001) had a significant effect upon VGlut1 mRNA in the overall ANOVA, and there was 
a significant genotype by area interaction (F12, 98=2.03, P=0.029). Individual ANOVAs 
detected effects of genotype upon VGlut1 mRNA in the DG, CA3, CA1, occipital and 
cingulate cortex, with a trend towards significance in the cerebellum (Table 3). These effects 
of genotype were due to decreases in VGlut1 mRNA expression in STOP null and 
heterozygotes as compared to wild type mice. 
 
GAP-43 mRNA 
The distribution of GAP-43 mRNA was as previously described (Cantallops and 
Routtenberg, 1999). As seen in humans, but not in rat, GAP-43 mRNA was robustly detected 
in the DG (see Eastwood and Harrison, 1998). Genotype (F2, 115=14.30, P<0.001) had a 
significant effect upon GAP-43 mRNA in the overall ANOVA, and there was a significant 
genotype by area interaction (F14, 115=2.48, P=0.004). Individual ANOVAs detected effects of 
genotype upon GAP-43 mRNA in the DG, CA3 and CA1, with a trend towards significance 
for genotype upon GAP-43 mRNA in the fronto-parietal cortex (Table 4). For DG, CA3 and 
CA1, the effects of genotype were due to decreases in expression as compared to wild type 
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mice, whilst for the fronto-parietal cortex, GAP-43 mRNA was increased in the null mice as 
compared to wild type mice. 
 
Spinophilin mRNA 
In agreement with previous reports in rats (Law et al., 2004a) and humans (Law et al., 
2004b), the distribution of spinophilin mRNA in mutant and wild type mice was consistent 
with a dendritic localization, with labelling observed not only over the pyramidal cell layer, 
but also adjacent strata of the DG and Ammon’s horn. Genotype (F2, 110=22.28, P<0.001) had 
a significant effect upon spinophilin mRNA in the overall ANOVA, and there was a 
significant genotype by area interaction (F14, 110=4.03, P<0.001). Subsequent individual 
ANOVAs found that genotype had a significant effect upon spinophilin mRNA in the DG, 
CA3, CA1 and cerebellum, with trends in the occipital and fronto-parietal cortex (Table 5). 
For the DG, CA3, CA1, occipital cortex and cerebellum, these were due to decreases in 
expression as compared to wild type mice, whilst for the fronto-parietal cortex, spinophilin 
mRNA was increased in the STOP null mice. 
 
MAP2 mRNA 
As reported above for spinophilin mRNA, and as observed in rats and humans (Tucker 
et al., 1989; Law et al., 2004a, b), MAP2 mRNA distribution in the STOP mutant and wild 
type mice is consistent with a dendritic localization.  For MAP2 mRNA in the overall 
ANOVA, neither a significant effect of genotype (F2, 110=2.15, P=0.122), nor a genotype by 
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GAPDH mRNA 
ISHH against the house keeping gene GAPDH was carried out, as an index of overall 
gene expression. No significant effects of genotype (F2, 102=2.51, P=0.09) nor genotype by 
area interactions (F14, 102=0.90, P=0.56) were detected (Table 7).  
 
Discussion 
The results of this study demonstrate that the expression of pre- and post-synaptic 
protein mRNAs is altered in STOP mutant mice. We will focus our discussion on how deficits 
in STOP and stabilized microtubules may lead to synaptic alterations. Similarities (and 
differences) between changes in synaptic protein expression exhibited by STOP null and 
heterozygous mice to those reported in schizophrenia will be discussed. Finally, we will 
comment upon the role which STOP or other cytoskeletal proteins may play in the origins of 
synaptic pathology in schizophrenia, including mediation of the potential influence of 
susceptibility genes. 
 
Synaptic protein mRNA expression as markers of synaptic pathology and their altered 
expression in STOP null and heterozygous mice 
The synaptic protein mRNAs examined in this study were chosen because they inform 
on different aspects of synapses, and on the basis of reports of their altered expression in post 
mortem studies of schizophrenia (see Table 1). The utilization of synaptic proteins as markers 
of synapses, and their mRNAs as markers of synaptic changes in the regions to which neurons 
project, has been reviewed elsewhere in depth (see Harrison and Eastwood, 2001; Honer et 
al., 2000; Honer and Young, 2003; Eastwood and Harrison, 2005) and will only be briefly 
mentioned here. Of the three pre-synaptic proteins studied, synaptophysin has been the mostly 
widely utilised, with alterations in its expression often being interpreted as indicative of 
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changes in overall synaptic density (or size), thereby denoting synaptic pathology (see 
Masliah et al., 1990; Eastwood et al., 1994). To provide an indication of any preferential 
involvement of excitatory or inhibitory neurons, pre-synaptic proteins selectively expressed 
by subpopulations of neurons have been used (see Harrison and Eastwood, 1998; Eastwood 
and Harrison, 2005). Of these, the vesicular glutamate transporter, VGlut1, which loads 
synaptic vesicles with glutamate, is exclusive to glutamatergic terminals (Bellochio et al., 
1998, 2000; Fremau et al., 2001). The last pre-synaptic protein examined in this study, GAP-
43, is a phosphoprotein involved in neurodevelopment, injury response and synaptic plasticity 
(see Benowitz and Routtenberg, 1997; Eastwood, 2003). Post-synaptic proteins have also 
been utilised as synaptic markers (see Law et al., 2004b). MAP2 is a general dendritic marker 
(Pollard et al., 1994), whilst spinophilin is specifically involved in dendritic spine formation 
and function (Feng et al., 2000). As most cortical glutamatergic synapses terminate on spines, 
altered spinophilin expression in the absence of any change of the expression of MAP2 is 
interpreted to indicate particular structural or functional involvement of spines and 
glutamatergic synapses. 
 Table 8 summarizes the differences in pre- and post-synaptic protein mRNA 
expression detected in STOP mutant mice as compared to their wild type littermates. Note 
that synaptic protein mRNA expression was decreased in both STOP null and heterozygous 
mice, whilst the mRNA for the housekeeping gene GAPDH was unchanged, indicating that 
altered synaptic protein mRNA expression is unlikely to be due to a generalized decrease in 
gene expression. As outlined above, the pattern of change in synaptic protein mRNA is 
indicative of synaptic alterations in STOP mutant mice. The finding that spinophilin (but not 
MAP2) and VGlut1 mRNAs are altered suggests that glutamatergic synapses are involved, 
though as markers of inhibitory synapses were not examined, it remains to be determined 
whether GABAergic synapses may be similarly affected. 
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As schizophrenia is considered a disorder of aberrant neurodevelopment, it will be 
interesting to determine when the synaptic changes noted in these adult STOP mutant mice 
first occur. Furthermore, as all behavioural studies conducted to date have focussed on the 
null mouse, it will also be interesting to determine whether heterozygous STOP mice also 
exhibit altered sensorimotor gating and locomotor activity (Fradley et al., 2005). If they do, 
the use of heterozygous mice in place of nulls would overcome practical limitations of 
generating sufficient numbers of mice (see Fradley et al., 2005). Finally, as the present study 
only examined females, examination of males will be necessary to establish whether there are 
sex differences in the molecular profile of STOP mutant mice.  
 
How may lack of STOP lead to synaptic deficits?  
Decreases of cold-stable microtubules exhibited by STOP null and heterozygous mice 
(Andrieux et al., 2002) are likely to influence neurodevelopmental processes, and ongoing 
adult synaptic plasticity, by perturbing microtubule dynamics and/or their interactions with 
molecular motors. Growth cone turning (Tanaka and Kirschner, 1995; Williamson et al., 
1996), axon pathfinding (Suter and Forscher, 2000; Schaefer et al., 2002), and axon branching 
(Dent et al., 2004; Kalil and Dent, 2005), are all dependent on interactions between 
microfilaments and microtubules, and changes in the dynamics of microtubules could 
potentially lead to abnormalities in the formation and maintenance of synaptic connections. 
Our data demonstrating that STOP null and heterozygous mice exhibit changes in the 
expression of pre- and post-synaptic proteins provides some molecular evidence in support of 
this. How such altered connectivity may occur will be discussed.  
 Microtubules function as rails along which kinesin superfamily proteins (KIFs) and 
dyneins act as molecular motors to transport intracellular cargoes such as mRNAs, protein 
complexes and organelles (Hirokawa and Takemura, 2004). Two KIFs, KIF1A and KIF1B, 
Altered synaptic protein mRNA expression in STOP mutant mice 13 
transport precursors of synaptic vesicles to axon terminals (Okada et al., 1995; Yonekawa et 
al., 1998; Zhao et al., 2001). Of particular relevance for the current study, knock out mice for 
KIF1A and KIF1B have reduced numbers of synaptic vesicles, indicating that our finding of 
decreased synaptophysin mRNA expression, and reductions in the number of synaptic 
vesicles in STOP mutant mice (Andrieux et al., 2002), may be caused by altered KIF function 
and diminished transport (and thence synthesis) of synaptic vesicles. The finding that 
treatment of STOP null mice with the microtubule stabilizing drug epothilone D partially 
returns to normal synaptic vesicle density (Andrieux et al., 2006) supports a role for 
microtubule stabilization in synaptic vesicle transport, and it will be interesting to determine if 
synaptophysin mRNA expression is likewise increased  
Given the importance of microtubules and their associated proteins in the formation 
and maintenance of dendrites (Liu et al., 2000; Yu et al., 2000; Scott and Luo, 2001; Jan and 
Jan, 2003), it might be predicted that deficits in cold stabilized microtubules in STOP mutant 
mice would lead to dendritic abnormalities. However, our data demonstrating decrements in 
spinophilin mRNA in the absence of alterations in that for MAP2, and the normal dendritic 
arborization observed in STOP null mice (Andrieux et al., 2002) suggest that changes in 
microtubule dynamics may instead preferentially affect spines. The presence of STOP 
(Andrieux et al., 2002) and microtubules (see van Rossum and Hanisch, 1999) in dendritic 
spines has been documented and stabilized microtubules are important in the transport and 
function of glutamate receptors, both during synaptogenesis and in adult synaptic plasiticity 
(Sergé et al., 2003; Washbourne et al., 2002, 2004; Yuen et al., 2005). Of note, the 
translocation of the RNA binding protein TLS (translocated in liposarcoma) into dendritic 
spines is dependent on stabilized microtubules, and hippocampal pyramidal neurons from 
TLS null mice exhibit decreased spine density and abnormal spine morphology (Fujii et al., 
2005). Together these data indicate that changes in microtubule dynamics in STOP deficient 
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mice may contribute to altered spine formation and/or function, and may underlie our findings 
of decreased spinophilin mRNA in STOP null and heterozygous mice.  
 
Are the present findings relevant to the understanding of schizophrenia? 
 The profile of change in expression of synaptic protein mRNAs seen here is quite 
similar to that observed in schizophrenia. For example, as in the hippocampus of STOP null 
and heterozygous mice (Table 8), post mortem studies mostly agree that, with the exception 
of MAP2 (see Table 1), synaptic protein mRNAs are reduced in the disorder. Although fewer 
studies have examined the cerebellum or occipital cortex in schizophrenia, synaptophysin 
mRNA is reportedly decreased in these areas too, consistent with the reduction seen in the 
STOP null mice. Concordance in findings between the STOP mutant mice and schizophrenia 
for the other brain areas examined here is difficult to determine, either because there are no 
comparable schizophrenia data (e.g. in cingulate cortex or caudate putamen) or because the 
rodent homologue of human dorsolateral prefrontal cortex is unclear.  
The above similarities, together with the previously described behavioural phenotype 
of the STOP mutant mice (Brun et al., 2005; Fradley et al., 2005), suggests that STOP is a 
candidate to contribute to the role which microtubules have been proposed to play in the 
pathophysiology of schizophrenia (Kerwin, 1993). Indeed, this candidacy recently received 
empirical support with the report of genetic association between STOP and schizophrenia 
(Shimizu et al., 2006). On the other hand, Shimizu et al. (2006) also found that one isoform of 
STOP mRNA was increased (and the other unchanged) in the prefrontal cortex in 
schizophrenia, arguing against a role for reduced STOP expression in the disorder. The 
situation remains unclear, however, since we have found STOP mRNA to be decreased in the 
hippocampus in schizophrenia (S.L.E. and P.J.H., unpublished observations). Thus, it remains 
to be determined whether STOP expression is altered in schizophrenia and, if so, whether this 
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is regionally specific. Clearly, the face validity of STOP null or heterozygous mice as a 
‘model’ of schizophrenia is affected by this issue. Equally, even if STOP expression is not 
found to be consistently reduced in schizophrenia, it does not negate the potential value of 
these mice, or the present findings, with regard to the disorder. Firstly, since STOP expression 
may have been reduced (and played its pathogenic role) in subjects with schizophrenia earlier 
in life, and subsequently normalised, perhaps due to antipsychotic medication. Secondly, the 
main significance of the present data is that they emphasise that alterations in synaptic protein 
gene expression, and synaptic functioning, can arise from “non-synaptic” mechanisms 
involving microtubules. As such, synaptic pathology in schizophrenia may have its origin 
elsewhere in the neuron (or even in non-neuronal cells). This is particularly relevant to our 
understanding of how susceptibility genes for schizophrenia may converge to alter synaptic 
function, given that most do not encode established structural components of the synapse or 
proteins known to be part of the synaptic proteome (see Grant et al., 2005; Harrison and 
Weinberger, 2005). Of note, one of the leading susceptibility genes, DISC1 (Disrupted in 
Schizophrenia 1), forms a complex with several proteins including NUDEL (nuclear 
distribution element-like) and Lis1 (lissencephaly gene 1 product), which binds to 
microtubules and is involved in neuronal migration and dynein-mediated motor transport (see 
Brandon et al., 2004; Kamiya et al., 2005.). The importance of this protein complex in axonal 
transport and dendritic morphogenesis has been demonstrated in Lis1 null Drosophila (Liu et 
al., 2000), whilst depletion of DISC1 or expression of a mutated form (mutDISC1) results in 
aberrant neuronal migration in vivo and impaired neurite outgrowth in vitro (Kamiya et al., 
2005). Interestingly, although DISC1 mRNA expression is not altered in schizophrenia, there 
are decrements in NUDEL and Lis1 mRNAs, associated with the DISC1 risk single 
nucleotide polymorphisms (Lipska et al., 2006), suggesting that DISC1 may exert its 
pathogenic effect in schizophrenia by impacting on the expression of its binding partners and 
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thereby alter microtubule dynamics and function.  One can speculate on a comparable role for 
STOP and its interacting proteins in schizophrenia.  
  
 Conclusions 
  The results of the current study complement data implicating microtubules in synaptic 
formation, maintenance and function, and give a precedent for altered microtubule dynamics 
producing changes in the molecular composition as well as functioning of synapses. Although 
serendipitously discovered, the STOP mutant mouse may be useful for studying aspects of the 
genetic pathophysiology of schizophrenia, especially its synaptic pathology and the roles that 
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Figure 1. Regional distribution of STOP mRNA. Representative autoradiographic images 
showing the distribution of STOP mRNA at the level of the dorsal hippocampus in wild type 
(A), heterozygous (C) and STOP null (E) mice, and at the level of the caudate putamen (B) 
and cerebellum (D) of wild type mice. F: Incubation with excess cold unlabelled probe, 
showing minimal background signal. CA: cornu Ammonis; CING: cingulate cortex; CPu: 
caudate putamen; DG: dentate gyrus; GCL: granule cell layer; FPC: fronto-parietal cortex; 
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Table 1. Summary of post mortem studies of pre- and post synaptic protein mRNA expression in 
schizophrenia.  
Brain Region  mRNA   Main Result  Study     
Hippocampus Synaptophysin  ↓   Eastwood et al., 1995.  
         Eastwood and Harrison, 1999.
         Webster et al., 2001.  
          
 
   VGlut1   ↓   Eastwood and Harrison, 2005. 
 
GAP-43  ↓   Eastwood and Harrison, 1998. 
 
   ↔   Webster et al., 2001.  
 
Spinophilin  ↓   Law et al., 2004a. 
 
MAP-2   ↔   Law et al., 2004a.  
   
              
DLPFC  Synaptophysin  ↔   Karson et al., 1999. 
         Eastwood et al., 2000.  
         Glantz et al., 2000. 
Weickert et al., 2004.  
    
  
VGlut1   ↓   Eastwood and Harrison, 2005. 
 
GAP-43  ↔   Eastwood and Harrison, 1998. 
 
   ↓   Weickert et al., 2001.  
   
   Spinophilin  ↔   Weickert et al., 2004.  
 
             
Occiptal Cortex Synaptophysin  ↓   Eastwood et al., 2000b. 
 




Cerebellum  Synaptophysin  ↓   Eastwood  et al., 2001. 
    
             
  
Summary is limited to published papers in brain regions relevant to those examined in mice in the current 
study. DLPFC: dorsolateral prefrontal cortex.         
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Table 2. Synaptophysin mRNA expression in wild type, heterozygous and STOP null mice. 
 
Area Effect of Genotype  Wild type Heterozygotes  Nulls 
 
 
DG F2, 14=2.66, P=0.105  1928 ± 75 1655 ± 134  1523 ± 115a 
 
CA3 F2, 14=0.67, P=0.532  3132 ± 97 2937 ± 112  2950 ± 180 
 
CA1 F2, 14=5.05, P=0.022  1981 ± 63 1654 ± 81b  1557 ± 131c 
 
OC F2, 14=7.99, P=0.005  1145 ± 50 1011 ± 29d  881 ± 58e 
 
FPC F2, 15=3.94, P=0.042  1092 ± 25 1013 ± 22f  1006 ± 23g 
 
CING F2, 15=3.03, P=0.079  1565 ± 57 1338 ± 49h  1340 ± 98i 
CPu F2, 15=0.61, P=0.554  292 ± 10 269 ± 15  280 ± 16 
CB F2, 14=3.08, P=0.078  998 ± 40 958 ± 72  793 ± 37j 
 
Values are mean 35SnCi/g tissue equivalents ± SEM. a P=0.041, b P=0.025, c P=0.010, d P=0.045, e 
P=0.001, f P=0.029, g P=0.022, h P=0.042, i P=0.050, j P=0.037, as compared to wild type. No 
significant differences were found between heterozygous and null mice.  CA: cornu Ammonis; CB: 
cerebellum; CING: cingulate cortex; CPu: caudate putamen; DG: dentate gyrus; FPC: fronto-parietal 
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Table 3. VGlut1 mRNA expression in wild type, heterozygous and STOP null mice. 
 
Area Effect of Genotype  Wild type Heterozygotes  Nulls 
 
DG F2, 14=4.68, P=0.028  2963 ± 229 2311 ± 138a  2233 ± 180b 
      
CA3 F2, 14=4.06, P=0.041  4985 ± 155 4114 ± 273c  4546 ± 110 
 
CA1 F2, 14=5.18, P=0.021  3359 ± 242 2602 ± 149d  2793 ± 106e 
 
OC F2, 14=5.18, P=0.021  1470 ± 66 1311 ± 56  1185 ± 53f 
 
FPC F2, 14=2.71, P=0.101  1248 ± 37 1221 ± 32  1104 ± 62g 
 
CING F2, 14=4.21, P=0.037  1560 ± 48 1368 ± 96  1131 ± 132h  
 
CB F2, 14=2.92, P=0.087  2036 ± 25 1936 ± 65  1821 ± 65i 
 
 
Values are mean 35SnCi/g tissue equivalents ± SEM . a P=0.020, b P=0.016, c P=0.013, d P=0.007, e 
P=0.046, f P=0.006, g P=0.050, h P=0.012, i P=0.030, as compared to wild types. No significant 
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Table 4. GAP-43 mRNA expression in wild type, heterozygous and STOP null mice. 
 
Area Effect of Genotype  Wild type Heterozygotes  Nulls 
 
 
DG F2, 14=5.02, P=0.023  1227 ± 103 918 ± 76a  917 ± 54b 
 
CA3 F2, 14=4.43, P=0.032  1560 ± 104 1242 ± 49c  1189 ± 113d 
 
CA1 F2, 14=5.01, P=0.023  1476 ± 195 993 ± 55e  991 ± 100f 
 
OC F2, 14=1.24, P=0.319  604 ± 90 562 ± 74  438 ± 70 
 
FPC F2, 15=3.38, P=0.062  109 ± 5 123 ± 7  136 ± 7g 
 
CING F2, 15=0.97, P=0.402  349 ± 33 293 ± 43  260 ± 48 
 
CPu F2, 14=0.15, P=0.866  159 ± 4 149 ± 6  149 ± 22 
 
CB F2, 14=1.55, P=0.248  1750 ± 44 1666 ± 56  1782 ± 37 
 
 
Values are mean 35SnCi/g tissue equivalents ± SEM. a P=0.015, b P=0.015, c P=0.031, d P=0.015, e 
P=0.015, f P=0.014, g P=0.020, compared to wild types. No significant differences were found 
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Table 5. Spinophilin  mRNA expression in wild type, heterozygous and STOP null mice. 
 
 
Area Effect of Genotype  Wild type Heterozygotes  Nulls 
 
 
DG F2, 13=13.26, P=0.001  365 ± 14 272 ± 13a  261 ± 15b 
CA3 F2, 13=4.27, P=0.038  267 ± 5 221 ± 11c  211 ± 18d 
CA1 F2, 13=4.23, P=0.038  249 ± 16 207 ± 14e  192 ± 6f 
OC F2, 13=3.18, P=0.075  138 ± 3 124 ± 3  118 ± 8g 
FPC F2, 15=3.45, P=0.059  34 ± 2  35 ± 3h   44 ± 4i 
CING F2, 15=1.27, P=0.310  80 ± 3  74 ± 4   82 ± 5   
    
CPu F2, 15=2.63, P=0.105  37 ± 2  36 ± 1j   45 ± 5 
 
CB F2, 13=4.09, P=0.042  675 ± 15 628 ± 20  580 ± 32k 
 
Values are mean 35SnCi/g tissue equivalents ± SEM. a P=0.001, b P<0.001, c P=0.033, d P=0.016, e 
P=0.043, f P=0.014, g P=0.027, i P=0.037,   k P=0.013, as compared to wild types. 
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Table 6. MAP2 mRNA expression in wild type, heterozygous and STOP null mice. 
 
Area  Wild type Heterozygotes  Nulls 
 
DG  1216 ± 36 1191 ± 30  1138 ± 88 
CA3  940 ± 46 971 ± 47  926 ± 33 
CA1  909 ± 19 938 ± 26  930 ± 22 
OC  617 ± 50 594 ± 90  605 ± 59 
FPC  584 ± 17 588 ± 22  566 ± 22 
CING  834 ± 30 802 ± 23  749 ± 27 
CPu  385 ± 11 395 ± 14  375 ± 16 
CB  713 ± 16 804 ± 20  723 ± 23c   
 
Values are mean 35SnCi/g tissue equivalents ± SEM. No overall effect of genotype, or genotype by 
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Table 7. GAPDH  mRNA expression in wild type, heterozygous and STOP null mice. 
 
Area  Wild type Heterozygotes  Nulls 
 
DG  1105 ± 22 1169 ± 68  1157 ± 35 
CA3  1793 ± 104 1871 ± 123  2102 ± 168 
CA1  1350 ± 87 1440 ± 59  1562 ± 56 
OC  677 ± 5 675 ± 5  670 ± 6 
FPC  371 ± 24 353 ± 14  397 ± 27 
CING  501 ± 40 470 ± 40  542 ± 44 
CPu  248 ± 15 238 ± 17  281 ± 19 
CB  863 ± 15 956 ± 102  847 ± 6.5 
 
Values are mean 35SnCi/g tissue equivalents ± SEM . No overall effect of genotype, or genotype by 
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Table 8. Summary of significant changes in mRNA expression detected between STOP mutants as compared to wild type mice. 
 
Area  STOP null mice      Heterozygous mice 
 SYN VGlut1 GAP-43 SPINO  SYN VGlut1 GAP-43 SPINO 
DG ↓ ↓ ↓ ↓  ↔ ↓ ↓ ↓ 
CA3 ↔ ↔ ↓ ↓  ↔ ↓ ↓ ↓ 
CA1 ↓ ↓ ↓ ↓  ↓ ↓ ↓ ↓ 
OC ↓ ↓ ↔ ↓  ↓ ↔ ↔ ↔ 
FPC ↓ ↓ ↑ ↑  ↓ ↔ ↔ ↔ 
CING ↓ ↓ ↔ ↔  ↓ ↔ ↔ ↔ 
CPu ↔ ND ↔ ↔  ↔ ND ↔ ↔ 




ND: no mRNA signal detected; SPINO: spinophilin; SYN: synaptophysin. Other abbreviations as in Table 2. 
  
